Pre-order Enquiry
Request Free Sample
Global Nonalcoholic Steatohepatitis Treatment Market Research Report 2020
SKU ID : QYR-16531810 | Publishing Date : 12-Oct-2020 | No. of pages : 118
Request Sample
Request Customization
Check DiscountsDetailed TOC of Global Nonalcoholic Steatohepatitis Treatment Market Research Report 2020
1 Nonalcoholic Steatohepatitis Treatment Market Overview1.1 Product Overview and Scope of Nonalcoholic Steatohepatitis Treatment
1.2 Nonalcoholic Steatohepatitis Treatment Segment by Type
1.2.1 Global Nonalcoholic Steatohepatitis Treatment Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 Solid
1.2.3 Liquid
1.3 Nonalcoholic Steatohepatitis Treatment Segment by Application
1.3.1 Nonalcoholic Steatohepatitis Treatment Sales Comparison by Application: 2020 VS 2026
1.3.2 Hospital
1.3.3 Diagnostic Center
1.3.4 Specialized Clinic
1.3.5 Hospital Pharmacy
1.3.6 Drug Store
1.3.7 Mail Order Pharmacy
1.4 Global Nonalcoholic Steatohepatitis Treatment Market Size Estimates and Forecasts
1.4.1 Global Nonalcoholic Steatohepatitis Treatment Revenue 2015-2026
1.4.2 Global Nonalcoholic Steatohepatitis Treatment Sales 2015-2026
1.4.3 Nonalcoholic Steatohepatitis Treatment Market Size by Region: 2020 Versus 2026
1.5 Nonalcoholic Steatohepatitis Treatment Industry
1.6 Nonalcoholic Steatohepatitis Treatment Market Trends
2 Global Nonalcoholic Steatohepatitis Treatment Market Competition by Manufacturers
2.1 Global Nonalcoholic Steatohepatitis Treatment Sales Market Share by Manufacturers (2015-2020)
2.2 Global Nonalcoholic Steatohepatitis Treatment Revenue Share by Manufacturers (2015-2020)
2.3 Global Nonalcoholic Steatohepatitis Treatment Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Nonalcoholic Steatohepatitis Treatment Manufacturing Sites, Area Served, Product Type
2.5 Nonalcoholic Steatohepatitis Treatment Market Competitive Situation and Trends
2.5.1 Nonalcoholic Steatohepatitis Treatment Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Nonalcoholic Steatohepatitis Treatment Players (Opinion Leaders)
3 Nonalcoholic Steatohepatitis Treatment Retrospective Market Scenario by Region
3.1 Global Nonalcoholic Steatohepatitis Treatment Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Nonalcoholic Steatohepatitis Treatment Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Nonalcoholic Steatohepatitis Treatment Market Facts & Figures by Country
3.3.1 North America Nonalcoholic Steatohepatitis Treatment Sales by Country
3.3.2 North America Nonalcoholic Steatohepatitis Treatment Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Nonalcoholic Steatohepatitis Treatment Market Facts & Figures by Country
3.4.1 Europe Nonalcoholic Steatohepatitis Treatment Sales by Country
3.4.2 Europe Nonalcoholic Steatohepatitis Treatment Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Nonalcoholic Steatohepatitis Treatment Market Facts & Figures by Region
3.5.1 Asia Pacific Nonalcoholic Steatohepatitis Treatment Sales by Region
3.5.2 Asia Pacific Nonalcoholic Steatohepatitis Treatment Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Nonalcoholic Steatohepatitis Treatment Market Facts & Figures by Country
3.6.1 Latin America Nonalcoholic Steatohepatitis Treatment Sales by Country
3.6.2 Latin America Nonalcoholic Steatohepatitis Treatment Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa Nonalcoholic Steatohepatitis Treatment Market Facts & Figures by Country
3.7.1 Middle East and Africa Nonalcoholic Steatohepatitis Treatment Sales by Country
3.7.2 Middle East and Africa Nonalcoholic Steatohepatitis Treatment Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Nonalcoholic Steatohepatitis Treatment Historic Market Analysis by Type
4.1 Global Nonalcoholic Steatohepatitis Treatment Sales Market Share by Type (2015-2020)
4.2 Global Nonalcoholic Steatohepatitis Treatment Revenue Market Share by Type (2015-2020)
4.3 Global Nonalcoholic Steatohepatitis Treatment Price Market Share by Type (2015-2020)
4.4 Global Nonalcoholic Steatohepatitis Treatment Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Global Nonalcoholic Steatohepatitis Treatment Historic Market Analysis by Application
5.1 Global Nonalcoholic Steatohepatitis Treatment Sales Market Share by Application (2015-2020)
5.2 Global Nonalcoholic Steatohepatitis Treatment Revenue Market Share by Application (2015-2020)
5.3 Global Nonalcoholic Steatohepatitis Treatment Price by Application (2015-2020)
6 Company Profiles and Key Figures in Nonalcoholic Steatohepatitis Treatment Business
6.1 AstraZeneca
6.1.1 Corporation Information
6.1.2 AstraZeneca Description, Business Overview and Total Revenue
6.1.3 AstraZeneca Nonalcoholic Steatohepatitis Treatment Sales, Revenue and Gross Margin (2015-2020)
6.1.4 AstraZeneca Products Offered
6.1.5 AstraZeneca Recent Development
6.2 Arena Pharmaceuticals
6.2.1 Arena Pharmaceuticals Corporation Information
6.2.2 Arena Pharmaceuticals Description, Business Overview and Total Revenue
6.2.3 Arena Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Sales, Revenue and Gross Margin (2015-2020)
6.2.4 Arena Pharmaceuticals Products Offered
6.2.5 Arena Pharmaceuticals Recent Development
6.3 GSK
6.3.1 GSK Corporation Information
6.3.2 GSK Description, Business Overview and Total Revenue
6.3.3 GSK Nonalcoholic Steatohepatitis Treatment Sales, Revenue and Gross Margin (2015-2020)
6.3.4 GSK Products Offered
6.3.5 GSK Recent Development
6.4 Novo Nordisk
6.4.1 Novo Nordisk Corporation Information
6.4.2 Novo Nordisk Description, Business Overview and Total Revenue
6.4.3 Novo Nordisk Nonalcoholic Steatohepatitis Treatment Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Novo Nordisk Products Offered
6.4.5 Novo Nordisk Recent Development
6.5 Roche
6.5.1 Roche Corporation Information
6.5.2 Roche Description, Business Overview and Total Revenue
6.5.3 Roche Nonalcoholic Steatohepatitis Treatment Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Roche Products Offered
6.5.5 Roche Recent Development
6.6 Vivus
6.6.1 Vivus Corporation Information
6.6.2 Vivus Description, Business Overview and Total Revenue
6.6.3 Vivus Nonalcoholic Steatohepatitis Treatment Sales, Revenue and Gross Margin (2015-2020)
6.6.4 Vivus Products Offered
6.6.5 Vivus Recent Development
6.7 Arisaph Pharmaceuticals
6.6.1 Arisaph Pharmaceuticals Corporation Information
6.6.2 Arisaph Pharmaceuticals Description, Business Overview and Total Revenue
6.6.3 Arisaph Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Arisaph Pharmaceuticals Products Offered
6.7.5 Arisaph Pharmaceuticals Recent Development
6.8 Cempra Pharmaceuticals
6.8.1 Cempra Pharmaceuticals Corporation Information
6.8.2 Cempra Pharmaceuticals Description, Business Overview and Total Revenue
6.8.3 Cempra Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Sales, Revenue and Gross Margin (2015-2020)
6.8.4 Cempra Pharmaceuticals Products Offered
6.8.5 Cempra Pharmaceuticals Recent Development
6.9 Galectin Therapeutics
6.9.1 Galectin Therapeutics Corporation Information
6.9.2 Galectin Therapeutics Description, Business Overview and Total Revenue
6.9.3 Galectin Therapeutics Nonalcoholic Steatohepatitis Treatment Sales, Revenue and Gross Margin (2015-2020)
6.9.4 Galectin Therapeutics Products Offered
6.9.5 Galectin Therapeutics Recent Development
6.10 Galmed Pharmaceuticals
6.10.1 Galmed Pharmaceuticals Corporation Information
6.10.2 Galmed Pharmaceuticals Description, Business Overview and Total Revenue
6.10.3 Galmed Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Sales, Revenue and Gross Margin (2015-2020)
6.10.4 Galmed Pharmaceuticals Products Offered
6.10.5 Galmed Pharmaceuticals Recent Development
6.11 Genfit
6.11.1 Genfit Corporation Information
6.11.2 Genfit Nonalcoholic Steatohepatitis Treatment Description, Business Overview and Total Revenue
6.11.3 Genfit Nonalcoholic Steatohepatitis Treatment Sales, Revenue and Gross Margin (2015-2020)
6.11.4 Genfit Products Offered
6.11.5 Genfit Recent Development
6.12 Gilead
6.12.1 Gilead Corporation Information
6.12.2 Gilead Nonalcoholic Steatohepatitis Treatment Description, Business Overview and Total Revenue
6.12.3 Gilead Nonalcoholic Steatohepatitis Treatment Sales, Revenue and Gross Margin (2015-2020)
6.12.4 Gilead Products Offered
6.12.5 Gilead Recent Development
7 Nonalcoholic Steatohepatitis Treatment Manufacturing Cost Analysis
7.1 Nonalcoholic Steatohepatitis Treatment Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Nonalcoholic Steatohepatitis Treatment
7.4 Nonalcoholic Steatohepatitis Treatment Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Nonalcoholic Steatohepatitis Treatment Distributors List
8.3 Nonalcoholic Steatohepatitis Treatment Customers
9 Market Dynamics
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis
10 Global Market Forecast
10.1 Global Nonalcoholic Steatohepatitis Treatment Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Nonalcoholic Steatohepatitis Treatment by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Nonalcoholic Steatohepatitis Treatment by Type (2021-2026)
10.2 Nonalcoholic Steatohepatitis Treatment Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Nonalcoholic Steatohepatitis Treatment by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Nonalcoholic Steatohepatitis Treatment by Application (2021-2026)
10.3 Nonalcoholic Steatohepatitis Treatment Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Nonalcoholic Steatohepatitis Treatment by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Nonalcoholic Steatohepatitis Treatment by Region (2021-2026)
10.4 North America Nonalcoholic Steatohepatitis Treatment Estimates and Projections (2021-2026)
10.5 Europe Nonalcoholic Steatohepatitis Treatment Estimates and Projections (2021-2026)
10.6 Asia Pacific Nonalcoholic Steatohepatitis Treatment Estimates and Projections (2021-2026)
10.7 Latin America Nonalcoholic Steatohepatitis Treatment Estimates and Projections (2021-2026)
10.8 Middle East and Africa Nonalcoholic Steatohepatitis Treatment Estimates and Projections (2021-2026)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Figures, Tables and Charts Available in Global Nonalcoholic Steatohepatitis Treatment Market Research Report 2020
List of TablesTable 1. Global Nonalcoholic Steatohepatitis Treatment Sales (K Units) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Nonalcoholic Steatohepatitis Treatment Sales (K Units) Comparison by Application: 2020 VS 2026
Table 3. Global Nonalcoholic Steatohepatitis Treatment Market Size by Type (K Units) (US$ Million) (2020 VS 2026)
Table 4. Global Key Nonalcoholic Steatohepatitis Treatment Manufacturers Covered in This Study
Table 5. Global Nonalcoholic Steatohepatitis Treatment Sales (K Units) by Manufacturers (2015-2020)
Table 6. Global Nonalcoholic Steatohepatitis Treatment Sales Share by Manufacturers (2015-2020)
Table 7. Global Nonalcoholic Steatohepatitis Treatment Revenue (Million USD) by Manufacturers (2015-2020)
Table 8. Global Nonalcoholic Steatohepatitis Treatment Revenue Share by Manufacturers (2015-2020)
Table 9. Global Market Nonalcoholic Steatohepatitis Treatment Average Price (US$/Unit) of Key Manufacturers (2015-2020)
Table 10. Manufacturers Nonalcoholic Steatohepatitis Treatment Sales Sites and Area Served
Table 11. Manufacturers Nonalcoholic Steatohepatitis Treatment Product Types
Table 12. Global Nonalcoholic Steatohepatitis Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Nonalcoholic Steatohepatitis Treatment by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nonalcoholic Steatohepatitis Treatment as of 2019)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Main Points Interviewed from Key Nonalcoholic Steatohepatitis Treatment Players
Table 16. Global Nonalcoholic Steatohepatitis Treatment Sales (K Units) by Region (2015-2020)
Table 17. Global Nonalcoholic Steatohepatitis Treatment Sales Market Share by Region (2015-2020)
Table 18. Global Nonalcoholic Steatohepatitis Treatment Revenue (Million US$) by Region (2015-2020)
Table 19. Global Nonalcoholic Steatohepatitis Treatment Revenue Market Share by Region (2015-2020)
Table 20. North America Nonalcoholic Steatohepatitis Treatment Sales by Country (2015-2020) (K Units)
Table 21. North America Nonalcoholic Steatohepatitis Treatment Sales Market Share by Country (2015-2020)
Table 22. North America Nonalcoholic Steatohepatitis Treatment Revenue by Country (2015-2020) (US$ Million)
Table 23. North America Nonalcoholic Steatohepatitis Treatment Revenue Market Share by Country (2015-2020)
Table 24. Europe Nonalcoholic Steatohepatitis Treatment Sales by Country (2015-2020) (K Units)
Table 25. Europe Nonalcoholic Steatohepatitis Treatment Sales Market Share by Country (2015-2020)
Table 26. Europe Nonalcoholic Steatohepatitis Treatment Revenue by Country (2015-2020) (US$ Million)
Table 27. Europe Nonalcoholic Steatohepatitis Treatment Revenue Market Share by Country (2015-2020)
Table 28. Asia Pacific Nonalcoholic Steatohepatitis Treatment Sales by Region (2015-2020) (K Units)
Table 29. Asia Pacific Nonalcoholic Steatohepatitis Treatment Sales Market Share by Region (2015-2020)
Table 30. Asia Pacific Nonalcoholic Steatohepatitis Treatment Revenue by Region (2015-2020) (US$ Million)
Table 31. Asia Pacific Nonalcoholic Steatohepatitis Treatment Revenue Market Share by Region (2015-2020)
Table 32. Latin America Nonalcoholic Steatohepatitis Treatment Sales by Country (2015-2020) (K Units)
Table 33. Latin America Nonalcoholic Steatohepatitis Treatment Sales Market Share by Country (2015-2020)
Table 34. Latin America Nonalcoholic Steatohepatitis Treatment Revenue by Country (2015-2020) (US$ Million)
Table 35. Latin America Nonalcoholic Steatohepatitis Treatment Revenue Market Share by Country (2015-2020)
Table 36. Middle East and Africa Nonalcoholic Steatohepatitis Treatment Sales by Country (2015-2020) (K Units)
Table 37. Middle East and Africa Nonalcoholic Steatohepatitis Treatment Sales Market Share by Country (2015-2020)
Table 38. Middle East and Africa Nonalcoholic Steatohepatitis Treatment Revenue by Country (2015-2020) (US$ Million)
Table 39. Middle East and Africa Nonalcoholic Steatohepatitis Treatment Revenue Market Share by Country (2015-2020)
Table 40. Global Nonalcoholic Steatohepatitis Treatment Sales (K Units) by Type (2015-2020)
Table 41. Global Nonalcoholic Steatohepatitis Treatment Sales Share by Type (2015-2020)
Table 42. Global Nonalcoholic Steatohepatitis Treatment Revenue (Million US$) by Type (2015-2020)
Table 43. Global Nonalcoholic Steatohepatitis Treatment Revenue Share by Type (2015-2020)
Table 44. Global Nonalcoholic Steatohepatitis Treatment Price (US$/Unit) by Type (2015-2020)
Table 45. Global Nonalcoholic Steatohepatitis Treatment Sales (K Units) by Application (2015-2020)
Table 46. Global Nonalcoholic Steatohepatitis Treatment Sales Market Share by Application (2015-2020)
Table 47. Global Nonalcoholic Steatohepatitis Treatment Sales Growth Rate by Application (2015-2020)
Table 48. AstraZeneca Nonalcoholic Steatohepatitis Treatment Corporation Information
Table 49. AstraZeneca Description and Business Overview
Table 50. AstraZeneca Nonalcoholic Steatohepatitis Treatment Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 51. AstraZeneca Main Product
Table 52. AstraZeneca Recent Development
Table 53. Arena Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Corporation Information
Table 54. Arena Pharmaceuticals Corporation Information
Table 55. Arena Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 56. Arena Pharmaceuticals Main Product
Table 57. Arena Pharmaceuticals Recent Development
Table 58. GSK Nonalcoholic Steatohepatitis Treatment Corporation Information
Table 59. GSK Corporation Information
Table 60. GSK Nonalcoholic Steatohepatitis Treatment Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 61. GSK Main Product
Table 62. GSK Recent Development
Table 63. Novo Nordisk Nonalcoholic Steatohepatitis Treatment Corporation Information
Table 64. Novo Nordisk Corporation Information
Table 65. Novo Nordisk Nonalcoholic Steatohepatitis Treatment Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 66. Novo Nordisk Main Product
Table 67. Novo Nordisk Recent Development
Table 68. Roche Nonalcoholic Steatohepatitis Treatment Corporation Information
Table 69. Roche Corporation Information
Table 70. Roche Nonalcoholic Steatohepatitis Treatment Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 71. Roche Main Product
Table 72. Roche Recent Development
Table 73. Vivus Nonalcoholic Steatohepatitis Treatment Corporation Information
Table 74. Vivus Corporation Information
Table 75. Vivus Nonalcoholic Steatohepatitis Treatment Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 76. Vivus Main Product
Table 77. Vivus Recent Development
Table 78. Arisaph Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Corporation Information
Table 79. Arisaph Pharmaceuticals Corporation Information
Table 80. Arisaph Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 81. Arisaph Pharmaceuticals Main Product
Table 82. Arisaph Pharmaceuticals Recent Development
Table 83. Cempra Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Corporation Information
Table 84. Cempra Pharmaceuticals Corporation Information
Table 85. Cempra Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 86. Cempra Pharmaceuticals Main Product
Table 87. Cempra Pharmaceuticals Recent Development
Table 88. Galectin Therapeutics Nonalcoholic Steatohepatitis Treatment Corporation Information
Table 89. Galectin Therapeutics Corporation Information
Table 90. Galectin Therapeutics Nonalcoholic Steatohepatitis Treatment Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 91. Galectin Therapeutics Main Product
Table 92. Galectin Therapeutics Recent Development
Table 93. Galmed Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Corporation Information
Table 94. Galmed Pharmaceuticals Corporation Information
Table 95. Galmed Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 96. Galmed Pharmaceuticals Main Product
Table 97. Galmed Pharmaceuticals Recent Development
Table 98. Genfit Nonalcoholic Steatohepatitis Treatment Corporation Information
Table 99. Genfit Corporation Information
Table 100. Genfit Nonalcoholic Steatohepatitis Treatment Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 101. Genfit Main Product
Table 102. Genfit Recent Development
Table 103. Gilead Nonalcoholic Steatohepatitis Treatment Corporation Information
Table 104. Gilead Corporation Information
Table 105. Gilead Nonalcoholic Steatohepatitis Treatment Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 106. Gilead Main Product
Table 107. Gilead Recent Development
Table 108. Sales Base and Market Concentration Rate of Raw Material
Table 109. Key Suppliers of Raw Materials
Table 110. Nonalcoholic Steatohepatitis Treatment Distributors List
Table 111. Nonalcoholic Steatohepatitis Treatment Customers List
Table 112. Market Key Trends
Table 113. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 114. Key Challenges
Table 115. Global Nonalcoholic Steatohepatitis Treatment Sales (K Units) Forecast by Type (2021-2026)
Table 116. Global Nonalcoholic Steatohepatitis Treatment Sales Market Share Forecast by Type (2021-2026)
Table 117. Global Nonalcoholic Steatohepatitis Treatment Revenue (Million US$) Forecast by Type (2021-2026)
Table 118. Global Nonalcoholic Steatohepatitis Treatment Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 119. Global Nonalcoholic Steatohepatitis Treatment Sales (K Units) Forecast by Application (2021-2026)
Table 120. Global Nonalcoholic Steatohepatitis Treatment Revenue (Million US$) Forecast by Application (2021-2026)
Table 121. Global Nonalcoholic Steatohepatitis Treatment Sales (K Units) Forecast by Region (2021-2026)
Table 122. Global Nonalcoholic Steatohepatitis Treatment Sales Market Share Forecast by Region (2021-2026)
Table 123. Global Nonalcoholic Steatohepatitis Treatment Revenue Forecast by Region (2021-2026) (US$ Million)
Table 124. Global Nonalcoholic Steatohepatitis Treatment Revenue Market Share Forecast by Region (2021-2026)
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources
List of Figures
Figure 1. Picture of Nonalcoholic Steatohepatitis Treatment
Figure 2. Global Nonalcoholic Steatohepatitis Treatment Sales Market Share by Type: 2020 VS 2026
Figure 3. Solid Product Picture
Figure 4. Liquid Product Picture
Figure 5. Global Nonalcoholic Steatohepatitis Treatment Consumption Market Share by Application: 2020 VS 2026
Figure 6. Hospital
Figure 7. Diagnostic Center
Figure 8. Specialized Clinic
Figure 9. Hospital Pharmacy
Figure 10. Drug Store
Figure 11. Mail Order Pharmacy
Figure 12. Global Nonalcoholic Steatohepatitis Treatment Market Size 2015-2026 (US$ Million)
Figure 13. Global Nonalcoholic Steatohepatitis Treatment Sales Capacity (K Units) (2015-2026)
Figure 14. Global Nonalcoholic Steatohepatitis Treatment Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Nonalcoholic Steatohepatitis Treatment Sales Share by Manufacturers in 2020
Figure 16. Global Nonalcoholic Steatohepatitis Treatment Revenue Share by Manufacturers in 2019
Figure 17. The Global 5 and 10 Largest Players: Market Share by Nonalcoholic Steatohepatitis Treatment Revenue in 2019
Figure 18. Nonalcoholic Steatohepatitis Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 19. Global Nonalcoholic Steatohepatitis Treatment Sales Market Share by Region (2015-2020)
Figure 20. Global Nonalcoholic Steatohepatitis Treatment Sales Market Share by Region in 2019
Figure 21. Global Nonalcoholic Steatohepatitis Treatment Revenue Market Share by Region (2015-2020)
Figure 22. Global Nonalcoholic Steatohepatitis Treatment Revenue Market Share by Region in 2019
Figure 23. North America Nonalcoholic Steatohepatitis Treatment Sales Market Share by Country in 2019
Figure 24. North America Nonalcoholic Steatohepatitis Treatment Revenue Market Share by Country in 2019
Figure 25. U.S. Nonalcoholic Steatohepatitis Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 26. U.S. Nonalcoholic Steatohepatitis Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 27. Canada Nonalcoholic Steatohepatitis Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 28. Canada Nonalcoholic Steatohepatitis Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 29. Europe Nonalcoholic Steatohepatitis Treatment Sales Market Share by Country in 2019
Figure 30. Europe Nonalcoholic Steatohepatitis Treatment Revenue Market Share by Country in 2019
Figure 31. Germany Nonalcoholic Steatohepatitis Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 32. Germany Nonalcoholic Steatohepatitis Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 33. France Nonalcoholic Steatohepatitis Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 34. France Nonalcoholic Steatohepatitis Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. U.K. Nonalcoholic Steatohepatitis Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 36. U.K. Nonalcoholic Steatohepatitis Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Italy Nonalcoholic Steatohepatitis Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 38. Italy Nonalcoholic Steatohepatitis Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. Russia Nonalcoholic Steatohepatitis Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 40. Russia Nonalcoholic Steatohepatitis Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 41. Asia Pacific Nonalcoholic Steatohepatitis Treatment Sales Market Share by Region in 2019
Figure 42. Asia Pacific Nonalcoholic Steatohepatitis Treatment Revenue Market Share by Region in 2019
Figure 43. China Nonalcoholic Steatohepatitis Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 44. China Nonalcoholic Steatohepatitis Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. Japan Nonalcoholic Steatohepatitis Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 46. Japan Nonalcoholic Steatohepatitis Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. South Korea Nonalcoholic Steatohepatitis Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 48. South Korea Nonalcoholic Steatohepatitis Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. India Nonalcoholic Steatohepatitis Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 50. India Nonalcoholic Steatohepatitis Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Australia Nonalcoholic Steatohepatitis Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 52. Australia Nonalcoholic Steatohepatitis Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Taiwan Nonalcoholic Steatohepatitis Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 54. Taiwan Nonalcoholic Steatohepatitis Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Indonesia Nonalcoholic Steatohepatitis Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 56. Indonesia Nonalcoholic Steatohepatitis Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Thailand Nonalcoholic Steatohepatitis Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 58. Thailand Nonalcoholic Steatohepatitis Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Malaysia Nonalcoholic Steatohepatitis Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 60. Malaysia Nonalcoholic Steatohepatitis Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Philippines Nonalcoholic Steatohepatitis Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 62. Philippines Nonalcoholic Steatohepatitis Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Vietnam Nonalcoholic Steatohepatitis Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 64. Vietnam Nonalcoholic Steatohepatitis Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. Latin America Nonalcoholic Steatohepatitis Treatment Sales Market Share by Country in 2019
Figure 66. Latin America Nonalcoholic Steatohepatitis Treatment Revenue Market Share by Country in 2019
Figure 67. Mexico Nonalcoholic Steatohepatitis Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 68. Mexico Nonalcoholic Steatohepatitis Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Brazil Nonalcoholic Steatohepatitis Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 70. Brazil Nonalcoholic Steatohepatitis Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Argentina Nonalcoholic Steatohepatitis Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 72. Argentina Nonalcoholic Steatohepatitis Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Middle East and Africa Nonalcoholic Steatohepatitis Treatment Sales Market Share by Country in 2019
Figure 74. Middle East and Africa Nonalcoholic Steatohepatitis Treatment Revenue Market Share by Country in 2019
Figure 75. Turkey Nonalcoholic Steatohepatitis Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 76. Turkey Nonalcoholic Steatohepatitis Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Saudi Arabia Nonalcoholic Steatohepatitis Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 78. Saudi Arabia Nonalcoholic Steatohepatitis Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. U.A.E Nonalcoholic Steatohepatitis Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 80. U.A.E Nonalcoholic Steatohepatitis Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Sales Market Share of Nonalcoholic Steatohepatitis Treatment by Type (2015-2020)
Figure 82. Sales Market Share of Nonalcoholic Steatohepatitis Treatment by Type in 2019
Figure 83. Revenue Share of Nonalcoholic Steatohepatitis Treatment by Type (2015-2020)
Figure 84. Revenue Market Share of Nonalcoholic Steatohepatitis Treatment by Type in 2019
Figure 85. Global Nonalcoholic Steatohepatitis Treatment Sales Growth by Type (2015-2020) (K Units)
Figure 86. Global Nonalcoholic Steatohepatitis Treatment Sales Market Share by Application (2015-2020)
Figure 87. Global Nonalcoholic Steatohepatitis Treatment Sales Market Share by Application in 2019
Figure 88. Global Revenue Share of Nonalcoholic Steatohepatitis Treatment by Application (2015-2020)
Figure 89. Global Revenue Share of Nonalcoholic Steatohepatitis Treatment by Application in 2020
Figure 90. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 91. Arena Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 92. GSK Total Revenue (US$ Million): 2019 Compared with 2018
Figure 93. Novo Nordisk Total Revenue (US$ Million): 2019 Compared with 2018
Figure 94. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 95. Vivus Total Revenue (US$ Million): 2019 Compared with 2018
Figure 96. Arisaph Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 97. Cempra Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 98. Galectin Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 99. Galmed Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 100. Genfit Total Revenue (US$ Million): 2019 Compared with 2018
Figure 101. Gilead Total Revenue (US$ Million): 2019 Compared with 2018
Figure 102. Price Trend of Key Raw Materials
Figure 103. Manufacturing Cost Structure of Nonalcoholic Steatohepatitis Treatment
Figure 104. Manufacturing Process Analysis of Nonalcoholic Steatohepatitis Treatment
Figure 105. Nonalcoholic Steatohepatitis Treatment Industrial Chain Analysis
Figure 106. Channels of Distribution
Figure 107. Distributors Profiles
Figure 108. Porter's Five Forces Analysis
Figure 109. North America Nonalcoholic Steatohepatitis Treatment Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 110. North America Nonalcoholic Steatohepatitis Treatment Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 111. Europe Nonalcoholic Steatohepatitis Treatment Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 112. Europe Nonalcoholic Steatohepatitis Treatment Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 113. Latin America Nonalcoholic Steatohepatitis Treatment Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 114. Latin America Nonalcoholic Steatohepatitis Treatment Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 115. Middle East and Africa Nonalcoholic Steatohepatitis Treatment Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 116. Middle East and Africa Nonalcoholic Steatohepatitis Treatment Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 117. Asia Pacific Nonalcoholic Steatohepatitis Treatment Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 118. Asia Pacific Nonalcoholic Steatohepatitis Treatment Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 119. Bottom-up and Top-down Approaches for This Report
Figure 120. Data Triangulation
Figure 121. Key Executives Interviewed
Keyplayers in Global Nonalcoholic Steatohepatitis Treatment Market Research Report 2020
AstraZenecaArena Pharmaceuticals
GSK
Novo Nordisk
Roche
Vivus
Arisaph Pharmaceuticals
Cempra Pharmaceuticals
Galectin Therapeutics
Galmed Pharmaceuticals
Genfit
Gilead
